{"denomUnitsSelected":"Participants","description":"-Progression-free survival (PFS) will be defined as time from ASCT to disease progression or relapse. Any patient who expires or withdraws prior to disease progression or relapse will be censored at last follow-up. Patients who are removed from study therapy prior to progression or relapse will be censored at the time of initiation of subsequent anti-myeloma treatment.","reportingStatus":"NOT_POSTED","timeFrame":"Up to 5 years post completion of treatment","title":"Progression-free Survival (PFS)","type":"SECONDARY"}